Skip to main content
Erschienen in: Drugs & Aging 8/2019

17.06.2019 | Original Research Article

Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative

verfasst von: Maarten Wauters, Monique Elseviers, Laurine Peeters, Dirk De Meester, Thierry Christiaens, Mirko Petrovic

Erschienen in: Drugs & Aging | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Background and Objective

Psychotropic drug use is high in nursing homes in Belgium. A practice improvement initiative (including education, professional support and the transition towards person-centred care) achieved significant reductions in psychotropic drug use. The initiative outline was transcribed into a general intervention template, and consequently implemented in five nursing homes (in mixed locations and with a mixed character) in preparation for a future broader roll-out in Belgium. The impact of the intervention on the use of psychotropic drugs in these five nursing homes is reported in this paper.

Methods

The general intervention template was fitted into the individual nursing home setting. Education for the nursing home personnel on psychotropic drugs and non-pharmacological alternatives, as well as details for a transition to person-centred care was provided. Psychotropic drug use was recorded using a dynamic cohort study design with cross-sectional observations (November 2016–November 2017).

Results

At baseline, participants’ (n = 677) mean age was 85.6 years (range 54–109 years), with 72.6% female. Mean medication intake was 8.5 (range 1–22), predominantly central nervous system drugs (Anatomic Therapeutic Chemical classification N, 88.8%). Long-term (> 3 months) psychotropic drug use (62.0%) and concomitant psychotropic drug use (31.5% taking two or more medications) were high. After 12 months, the prevalence of long-term psychotropic drug use decreased significantly (from 62.0 to 52.9%, p < 0.001), likewise the combined use of psychotropic drugs (from 31.5 to 24.0%, p = 0.001). The decrease in the prevalence of antidepressant and hypnosedative use was significant (respectively, from 32.2 to 23.4%, p < 0.001, and from 35.3 to 28.7%, p = 0.006) in contrast to antipsychotic use (from 17.1 to 15.9%, p = 0.522).

Conclusions

The stand-alone adaptation of the previously reported initiative using a general template was possible. This intervention resulted in a significant decrease in psychotropic drug use (predominantly hypnosedatives and antidepressants) among nursing home residents after 12 months.
Literatur
1.
Zurück zum Zitat Schüssler S, Dassen T, Lohrmann C. Care dependency and nursing care problems in nursing home residents with and without dementia: a cross-sectional study. Aging Clin Exp Res. 2016;28:973–82.CrossRefPubMed Schüssler S, Dassen T, Lohrmann C. Care dependency and nursing care problems in nursing home residents with and without dementia: a cross-sectional study. Aging Clin Exp Res. 2016;28:973–82.CrossRefPubMed
2.
Zurück zum Zitat Ivanova I, Wauters M, Stichele RV, Christiaens T, De Wolf J, Dilles T, et al. Medication use in a cohort of newly admitted nursing home residents (Ageing@NH) in relation to evolving physical and mental health. Arch Gerontol Geriatr. 2018;75:202–8.CrossRefPubMed Ivanova I, Wauters M, Stichele RV, Christiaens T, De Wolf J, Dilles T, et al. Medication use in a cohort of newly admitted nursing home residents (Ageing@NH) in relation to evolving physical and mental health. Arch Gerontol Geriatr. 2018;75:202–8.CrossRefPubMed
3.
Zurück zum Zitat Mann E, Köpke S, Haastert B, Pitkälä K, Meyer G, Alanen H, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009;9:18.CrossRefPubMedPubMedCentral Mann E, Köpke S, Haastert B, Pitkälä K, Meyer G, Alanen H, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009;9:18.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Hollingworth SA, Siskind DJ, Nissen LM, Robinson M, Hall WD. Patterns of antipsychotic medication use in Australia 2002–2007. Aust N Z J Psychiatry. 2010;44:372–7.CrossRefPubMed Hollingworth SA, Siskind DJ, Nissen LM, Robinson M, Hall WD. Patterns of antipsychotic medication use in Australia 2002–2007. Aust N Z J Psychiatry. 2010;44:372–7.CrossRefPubMed
5.
Zurück zum Zitat Sterke CS, van Beeck EF, van der Velde N, Ziere G, Petrovic M, Looman CWN, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52:947–55.CrossRefPubMed Sterke CS, van Beeck EF, van der Velde N, Ziere G, Petrovic M, Looman CWN, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52:947–55.CrossRefPubMed
6.
Zurück zum Zitat National Institute for Health and Care Excellence (UK). Dementia: assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (UK); 2018. National Institute for Health and Care Excellence (UK). Dementia: assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (UK); 2018.
7.
Zurück zum Zitat Barnes TRE, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry. 2012;201:221–6.CrossRefPubMed Barnes TRE, Banerjee S, Collins N, Treloar A, McIntyre SM, Paton C. Antipsychotics in dementia: prevalence and quality of antipsychotic drug prescribing in UK mental health services. Br J Psychiatry. 2012;201:221–6.CrossRefPubMed
8.
Zurück zum Zitat Selbæk G, Kirkevold Ø, Engedal K. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes: a 12-month follow-up study. Am J Geriatr Psychiatry. 2008;16:528–36.CrossRefPubMed Selbæk G, Kirkevold Ø, Engedal K. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes: a 12-month follow-up study. Am J Geriatr Psychiatry. 2008;16:528–36.CrossRefPubMed
9.
Zurück zum Zitat Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed
10.
Zurück zum Zitat Azermai M, Elseviers M, Petrovic M, Van Bortel L, Vander Stichele R. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol. 2011;26:12–20.CrossRefPubMed Azermai M, Elseviers M, Petrovic M, Van Bortel L, Vander Stichele R. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum Psychopharmacol. 2011;26:12–20.CrossRefPubMed
11.
Zurück zum Zitat Elseviers MM, Vander Stichele RR, Van Bortel L. Quality of prescribing in Belgian nursing homes: an electronic assessment of the medication chart. Int J Qual Health Care. 2014;26:93–9.CrossRefPubMed Elseviers MM, Vander Stichele RR, Van Bortel L. Quality of prescribing in Belgian nursing homes: an electronic assessment of the medication chart. Int J Qual Health Care. 2014;26:93–9.CrossRefPubMed
12.
Zurück zum Zitat Anrys PMS, Strauven GC, Foulon V, Degryse J-M, Henrard S, Spinewine A. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19:884–90.CrossRefPubMed Anrys PMS, Strauven GC, Foulon V, Degryse J-M, Henrard S, Spinewine A. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19:884–90.CrossRefPubMed
13.
Zurück zum Zitat Azermai M, Wauters M, De Meester D, Renson L, Pauwels D, Peeters L, et al. A quality improvement initiative on the use of psychotropic drugs in nursing homes in Flanders. Acta Clin Belg. 2017;72:163–71.CrossRefPubMed Azermai M, Wauters M, De Meester D, Renson L, Pauwels D, Peeters L, et al. A quality improvement initiative on the use of psychotropic drugs in nursing homes in Flanders. Acta Clin Belg. 2017;72:163–71.CrossRefPubMed
14.
Zurück zum Zitat De Vriendt P, Cornelis E, Vanbosseghem R, Desmet V, Van de Velde D. Enabling meaningful activities and quality of life in long-term care facilities: the stepwise development of a participatory client-centred approach in Flanders. Br J Occup Ther. 2019;82(1):15–26. https://doi.org/10.1177/0308022618775880.CrossRef De Vriendt P, Cornelis E, Vanbosseghem R, Desmet V, Van de Velde D. Enabling meaningful activities and quality of life in long-term care facilities: the stepwise development of a participatory client-centred approach in Flanders. Br J Occup Ther. 2019;82(1):15–26. https://​doi.​org/​10.​1177/​0308022618775880​.CrossRef
15.
Zurück zum Zitat Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä S-L, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55:809–17.CrossRefPubMed Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä S-L, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55:809–17.CrossRefPubMed
16.
Zurück zum Zitat Stevenson DG, Decker SL, Dwyer LL, Huskamp HA, Grabowski DC, Metzger ED, et al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry. 2010;18:1078–92.CrossRefPubMedPubMedCentral Stevenson DG, Decker SL, Dwyer LL, Huskamp HA, Grabowski DC, Metzger ED, et al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry. 2010;18:1078–92.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Stock KJ, Amuah JE, Lapane KL, Hogan DB, Maxwell CJ. Prevalence of, and resident and facility characteristics associated with antipsychotic use in assisted living vs. long-term care facilities: a cross-sectional analysis from Alberta, Canada. Drugs Aging. 2017;34:39–53. Stock KJ, Amuah JE, Lapane KL, Hogan DB, Maxwell CJ. Prevalence of, and resident and facility characteristics associated with antipsychotic use in assisted living vs. long-term care facilities: a cross-sectional analysis from Alberta, Canada. Drugs Aging. 2017;34:39–53.
18.
Zurück zum Zitat van der Spek K, Gerritsen DL, Smalbrugge M, Nelissen-Vrancken MHJMG, Wetzels RB, Smeets CHW, et al. Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate: the PROPER I-study. Int Psychogeriatrics. 2016;28:1589–95. van der Spek K, Gerritsen DL, Smalbrugge M, Nelissen-Vrancken MHJMG, Wetzels RB, Smeets CHW, et al. Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate: the PROPER I-study. Int Psychogeriatrics. 2016;28:1589–95.
19.
Zurück zum Zitat Allers K, Dörks M, Schmiemann G, Hoffmann F. Antipsychotic drug use in nursing home residents with and without dementia. Int Clin Psychopharmacol. 2017;32:213–8.CrossRefPubMed Allers K, Dörks M, Schmiemann G, Hoffmann F. Antipsychotic drug use in nursing home residents with and without dementia. Int Clin Psychopharmacol. 2017;32:213–8.CrossRefPubMed
20.
Zurück zum Zitat MacPherson S, Davison TE, Hallford D, Mellor D, Seedy M, Bird M, et al. Behavioral symptoms of dementia that present management difficulties in nursing homes: staff perceptions and their concordance with informant scales. J Gerontol Nurs. 2016;43:34–43.PubMed MacPherson S, Davison TE, Hallford D, Mellor D, Seedy M, Bird M, et al. Behavioral symptoms of dementia that present management difficulties in nursing homes: staff perceptions and their concordance with informant scales. J Gerontol Nurs. 2016;43:34–43.PubMed
21.
Zurück zum Zitat Tjia J, Lemay CA, Bonner A, Compher C, Paice K, Field T, et al. Informed family member involvement to improve the quality of dementia care in nursing homes. J Am Geriatr Soc. 2017;65:59–65.CrossRefPubMed Tjia J, Lemay CA, Bonner A, Compher C, Paice K, Field T, et al. Informed family member involvement to improve the quality of dementia care in nursing homes. J Am Geriatr Soc. 2017;65:59–65.CrossRefPubMed
22.
Zurück zum Zitat Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;(3):CD007726. Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;(3):CD007726.
23.
Zurück zum Zitat Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AI, Vander Stichele R, Declercq T, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018;3:CD007726. Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AI, Vander Stichele R, Declercq T, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018;3:CD007726.
24.
Zurück zum Zitat Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AI, Stichele R Vander, Declercq T, et al. Discontinuation of long-term antipsychotic drug use for behavioral and psychological symptoms in older adults aged 65 years and older with dementia. J Am Med Dir Assoc. 2018;19:1009–14. Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AI, Stichele R Vander, Declercq T, et al. Discontinuation of long-term antipsychotic drug use for behavioral and psychological symptoms in older adults aged 65 years and older with dementia. J Am Med Dir Assoc. 2018;19:1009–14.
25.
Zurück zum Zitat Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry. 2014;204:98–107.CrossRefPubMed Gould RL, Coulson MC, Patel N, Highton-Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials. Br J Psychiatry. 2014;204:98–107.CrossRefPubMed
26.
Zurück zum Zitat de Souto Barreto P, Lapeyre-Mestre M, Cestac P, Vellas B, Rolland Y. Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation. Br J Clin Pharmacol. 2016;81:759–67.CrossRef de Souto Barreto P, Lapeyre-Mestre M, Cestac P, Vellas B, Rolland Y. Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation. Br J Clin Pharmacol. 2016;81:759–67.CrossRef
27.
Zurück zum Zitat Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2010;22:26–36.CrossRefPubMed Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2010;22:26–36.CrossRefPubMed
28.
Zurück zum Zitat Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S. A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr. 2011;23:1260–9.CrossRefPubMed Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S. A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr. 2011;23:1260–9.CrossRefPubMed
29.
Zurück zum Zitat Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018;208:398–403.CrossRefPubMed Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018;208:398–403.CrossRefPubMed
30.
Zurück zum Zitat Richter T, Mann E, Meyer G, Haastert B, Köpke S. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med. Dir Assoc. 2012;13(187):e7–13. Richter T, Mann E, Meyer G, Haastert B, Köpke S. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med. Dir Assoc. 2012;13(187):e7–13.
31.
Zurück zum Zitat Hughes CM, Lapane K, Watson MC, Davies HTO. Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging. 2007;24:81–93.CrossRefPubMed Hughes CM, Lapane K, Watson MC, Davies HTO. Does organisational culture influence prescribing in care homes for older people? A new direction for research. Drugs Aging. 2007;24:81–93.CrossRefPubMed
32.
Zurück zum Zitat Leten L, Azermai M, Wauters M, De Lepeleire J. Een kwalitatieve exploratie van het chronisch gebruik van psychofarmaca in woonzorgcentraA qualitative exploration of the chronic use of psychotropic drugs in nursing homes. Tijdschr Gerontol Geriatr. 2017;48:177–86.CrossRefPubMed Leten L, Azermai M, Wauters M, De Lepeleire J. Een kwalitatieve exploratie van het chronisch gebruik van psychofarmaca in woonzorgcentraA qualitative exploration of the chronic use of psychotropic drugs in nursing homes. Tijdschr Gerontol Geriatr. 2017;48:177–86.CrossRefPubMed
33.
Zurück zum Zitat Cabrera E, Sutcliffe C, Verbeek H, Saks K, Soto-Martin M, Meyer G, et al. Non-pharmacological interventions as a best practice strategy in people with dementia living in nursing homes: a systematic review. Eur Geriatr Med. 2015;6:134–50.CrossRef Cabrera E, Sutcliffe C, Verbeek H, Saks K, Soto-Martin M, Meyer G, et al. Non-pharmacological interventions as a best practice strategy in people with dementia living in nursing homes: a systematic review. Eur Geriatr Med. 2015;6:134–50.CrossRef
34.
Zurück zum Zitat Chen R-C, Liu C-L, Lin M-H, Peng L-N, Chen L-Y, Liu L-K, et al. Non-pharmacological treatment reducing not only behavioral symptoms, but also psychotic symptoms of older adults with dementia: a prospective cohort study in Taiwan. Geriatr Gerontol Int. 2014;14:440–6.CrossRefPubMed Chen R-C, Liu C-L, Lin M-H, Peng L-N, Chen L-Y, Liu L-K, et al. Non-pharmacological treatment reducing not only behavioral symptoms, but also psychotic symptoms of older adults with dementia: a prospective cohort study in Taiwan. Geriatr Gerontol Int. 2014;14:440–6.CrossRefPubMed
35.
Zurück zum Zitat Martin P, Tannenbaum C, Ahmed S, Tamblyn R, Benedetti A. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education. JAMA Intern Med. 2014;174:890–8.CrossRefPubMed Martin P, Tannenbaum C, Ahmed S, Tamblyn R, Benedetti A. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education. JAMA Intern Med. 2014;174:890–8.CrossRefPubMed
36.
Zurück zum Zitat Lawrence V, Fossey J, Ballard C, Moniz-Cook E, Murray J. Improving quality of life for people with dementia in care homes: making psychosocial interventions work. Br J Psychiatry. 2012;201:344–51.CrossRefPubMed Lawrence V, Fossey J, Ballard C, Moniz-Cook E, Murray J. Improving quality of life for people with dementia in care homes: making psychosocial interventions work. Br J Psychiatry. 2012;201:344–51.CrossRefPubMed
Metadaten
Titel
Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative
verfasst von
Maarten Wauters
Monique Elseviers
Laurine Peeters
Dirk De Meester
Thierry Christiaens
Mirko Petrovic
Publikationsdatum
17.06.2019
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 8/2019
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-019-00686-5

Weitere Artikel der Ausgabe 8/2019

Drugs & Aging 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.